Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 161

Results For "Inc"

7943 News Found

AstraZeneca appoints Laura Colon as new President of Spain
People | January 10, 2026

AstraZeneca appoints Laura Colon as new President of Spain

After leading AstraZeneca's Oncology areas nationally and internationally, Laura Colón will assume the presidency of AstraZeneca in one of its priority global markets


Revvity and Lilly partner to accelerate AI drug discovery models
Digitisation | January 10, 2026

Revvity and Lilly partner to accelerate AI drug discovery models

Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering


Shilpa Medicare aims for US approval of chemo nausea drug
News | January 09, 2026

Shilpa Medicare aims for US approval of chemo nausea drug

Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections


IMCD opens beauty, personal Care laboratory in California
R&D | January 09, 2026

IMCD opens beauty, personal Care laboratory in California

The new facility offers an expanded laboratory alongside meeting areas dedicated to development meetings, formulation workshops, and brainstorming sessions


Alkem launches innovative hair growth support therapy kit
News | January 09, 2026

Alkem launches innovative hair growth support therapy kit

The supplements are made using only vegetarian-sourced ingredients


WHO unveils updated HIV guidelines to boost treatment & save lives
News | January 09, 2026

WHO unveils updated HIV guidelines to boost treatment & save lives

The guidelines also support reusing tenofovir and abacavir in later regimens for improved outcomes, cost savings, and programmatic efficiency


Nimbus Therapeutics and Eli Lilly team up on novel obesity therapy
News | January 09, 2026

Nimbus Therapeutics and Eli Lilly team up on novel obesity therapy

The partnership builds on a prior collaboration between Nimbus and Lilly targeting AMPK in cardiometabolic diseases


Iksuda reports promising early results for HER2-targeted therapy in oesophageal cancer
Clinical Trials | January 09, 2026

Iksuda reports promising early results for HER2-targeted therapy in oesophageal cancer

The Phase 1 study, a non-randomised, open-label, multicentre trial, is evaluating IKS014 in patients with locally advanced or metastatic solid tumours expressing HER2